Discover
HIMS
Hims & Hers Health, Inc.
30.92
300 x 30.93
1600 x 30.96
bid
ask
+
2.86
10.19%
950 @ 07:59 PM
30.93 +0.01 (0.03%)
| Ytd | -4.77% | |
| 1y | -46.92% |
28.31
day range
31.45
14.52
52 week range
62.76
| Open | 28.34 | Prev Close | 28.06 | Low | 28.31 | High | 31.45 | Mkt Cap | 7.21B |
| Vol | 16.03M | Avg Vol | 12.05M | EPS | -0.64 | P/E | N/A | Forward P/E | 41.93 |
| Beta | 2.43 | Short Ratio | 4.92 | Inst. Own | 71.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 29.37 | 200-d Avg | 27.41 | 1yr Est | 31.15 |
| Income Statement | |||
| Total Revenue | 753.21M | ||
| Revenues (USD) | 753.21M | ||
| Cost of Revenue | 272.41M | ||
| Gross Profit | 480.80M | ||
| Operating Expenses | 578.00M | ||
| Research and Development Expense | 54.90M | ||
| Selling, General and Administrative Expense | 427.61M | ||
| Operating Income | -97.19M | ||
| Income Tax Expense | -6.34M | ||
| Net Income | -86.29M | ||
| Net Income Common Stock | -86.29M | ||
| Net Income Common Stock (USD) | -86.29M | ||
| Consolidated Income | -86.29M | ||
| Earnings per Basic Share | -0.37 | ||
| Earnings per Basic Share (USD) | -0.37 | ||
| Earnings per Diluted Share | -0.37 | ||
| Earning Before Interest & Taxes (EBIT) | -92.63M | ||
| Earning Before Interest & Taxes (USD) | -92.63M | ||
| Weighted Average Shares | 231.75M | ||
| Weighted Average Shares Diluted | 231.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 609.81M | ||
| Cash and Equivalents (USD) | 609.81M | ||
| Investments | 231.24M | ||
| Investments Current | 231.24M | ||
| Trade and Non-Trade Receivables | 375.29M | ||
| Current Assets | 1.38B | ||
| Property, Plant & Equipment Net | 529.78M | ||
| Total Assets | 3.63B | ||
| Debt Current | 11.55M | ||
| Total Debt | 1.55B | ||
| Current Liabilities | 1.48B | ||
| Debt Non-Current | 1.53B | ||
| Total Liabilities | 3.30B | ||
| Accumulated Retained Earnings (Deficit) | -292.18M | ||
| Accumulated Other Comprehensive Income | -46.04M | ||
| Shareholders Equity | 324.07M | ||
| Shareholders Equity (USD) | 324.07M | ||
| Assets Non-Current | 2.24B | ||
| Total Debt (USD) | 1.55B | ||
| Deferred Revenue | 141.38M | ||
| Goodwill and Intangible Assets | 1.52B | ||
| Inventory | 87.78M | ||
| Liabilities Non-Current | 1.82B | ||
| Trade and Non-Trade Payables | 1.20B | ||
| Tax Assets | 111.58M | ||
| Tax Liabilities | 30.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 34.38M | ||
| Net Cash Flow from Financing | 341.76M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 387.55M | ||
| Capital Expenditure | -32.25M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -180.24M | ||
| Issuance (Purchase) of Equity Shares | 11.87M | ||
| Issuance (Repayment) of Debt Securities | 353.01M | ||
| Net Cash Flow from Investing | 84.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 297.03M | ||
| Net Cash Flow from Operations | -35.94M | ||
| Effect of Exchange Rate Changes on Cash | -2.81M | ||
| Share Based Compensation | 42.12M | ||